Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matzner, Y.
Right arrow Articles by Babior, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matzner, Y.
Right arrow Articles by Babior, B. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Diminished activity of a chemotactic inhibitor in synovial fluids from patients with familial Mediterranean fever

Y Matzner, RE Partridge, M Levy and BM Babior

Synovial fluids from patients with osteoarthritis contain a chemotactic inhibitor that acts by antagonizing the complement-derived chemotactic anaphylotoxin, C5a. The activity of this inhibitor in synovial fluids from patients with several forms of inflammatory arthritis (rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, and gout) were comparable to the activity present in osteoarthritic synovial fluids. In contrast, levels of inhibitory activity in synovial fluids from 9 patients with familial Mediterranean fever were decreased to less than 20% of those found in osteoarthritis fluids. The possibility was considered that the diminished inhibitory activity in fluids from patients with familial Mediterranean fever plays a part in the pathogenesis of the inflammatory attacks characteristic of this disease.

Volume 63, Issue 3, pp. 629-633, 03/01/1984
Copyright © 1984 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
Y. Matzner, S. Abedat, E. Shapiro, S. Eisenberg, A. Bar-Gil-Shitrit, P. Stepensky, S. Calco, Y. Azar, and S. Urieli-Shoval
Expression of the familial Mediterranean fever gene and activity of the C5a inhibitor in human primary fibroblast cultures
Blood, July 15, 2000; 96(2): 727 - 731.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. B. Watkins, F. M. Graeme-Cook, and J. Samuels
Case 25-1999- A 16-Year-Old Boy with Recurrent Abdominal Pain
N. Engl. J. Med., August 19, 1999; 341(8): 593 - 599.
[Full Text] [PDF]


Home page
NEJMHome page
B. M. Babior and Y. Matzner
The Familial Mediterranean Fever Gene -- Cloned at Last
N. Engl. J. Med., November 20, 1997; 337(21): 1548 - 1549.
[Full Text]


Home page
Arch Intern MedHome page
Y. Matzner, S. K. Ayesh, D. Hochner-Celniker, Z. Ackerman, and M. Ferne
Proposed Mechanism of the Inflammatory Attacks in Familial Mediterranean Fever
Arch Intern Med, June 1, 1990; 150(6): 1289 - 1291.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
A. Brauman and Y. Gilboa
Recurrent Pulmonary Atelectasis as a Manifestation of Familial Mediterranean Fever
Arch Intern Med, February 1, 1987; 147(2): 378 - 379.
[Abstract] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1984 by American Society of Hematology         Online ISSN: 1528-0020